What are GLP-1 drugs and why have they become so central to Lilly’s business?
Replied byDave Ricks
Chair & CEO at Eli Lilly and Company
Niche: Pharmaceuticals, AI, Health & Wellness
Revenue: $1M+/month
Location: USA
Started: 2015 or
GLP-1 drugs began as diabetes treatments and proved powerful for weight loss. They act on brain and gut pathways for appetite, glucose, and energy. For many people they bring sustained double-digit weight loss with health benefits, so demand exploded. Our job is to scale factories, supply chains, and long-term evidence to match that responsibility.
0
From the Full Interview
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Cite This Answer
Use this answer in your research, article, or academic work
Related Answers
Can you tell us how the business started and what that means to you today?
By Paul Guyett
Retail
$1M+/mo
What leadership lesson stands out from managing a long-established company?
By Paul Guyett
Retail
$1M+/mo
How did customers react when you moved locations?
By Paul Guyett
Retail
$1M+/mo
Why was improving the showroom layout important?
By Paul Guyett
Retail
$1M+/mo
How important is industry knowledge to your business?
By Paul Guyett
Retail
$1M+/mo
Why did you decide to create your own brands?
By Paul Guyett
Retail
$1M+/mo
How do you approach quality versus cost decisions?
By Paul Guyett
Retail
$1M+/mo